What is the most common cause of immune complex-associated membranoproliferative glomerulonephritis (MPGN) in the adult population?
Cholemic nephrosis is seen in:
Which of the following is a cause of leprosy?
KIM-1 is a novel biomarker for which of the following conditions?
Which of the following conditions is associated with pauci-immune crescentic glomerulonephritis?
A patient presented with hematuria and acute renal failure. Renal biopsy showed crescentic glomerulonephritis with immunofluorescence findings of C3 and IgG deposition. What is the most likely diagnosis?
Which of the following is specifically associated with infection with Schistosoma haematobium?
Nodular glomerulosclerosis is a characteristic finding in which of the following conditions?
Which of the following statements are true regarding autosomal dominant polycystic kidney disease (ADPKD)?
In the rejection phenomenon after kidney transplant, what is the primary target for early immunological attack?
Explanation: **Explanation:** Membranoproliferative Glomerulonephritis (MPGN) is a pattern of glomerular injury characterized by basement membrane thickening and mesangial proliferation [1]. Under the current classification, MPGN is divided into **Immune Complex-mediated** (driven by classical pathway activation) and **Complement-mediated** (C3 glomerulopathy) [2]. **Why Option A is Correct:** In the adult population, immune complex-mediated MPGN is most commonly **secondary** to chronic infections [1]. Among these, **Hepatitis C Virus (HCV)**—often associated with cryoglobulinemia—and **Hepatitis B Virus (HBV)** are the most frequent triggers [1]. These chronic hepatotropic viral infections lead to persistent antigenemia, forming circulating immune complexes that deposit in the subendothelial space, triggering the "tram-track" appearance of the glomerular basement membrane [1]. **Analysis of Incorrect Options:** * **B. Essential mixed cryoglobulinemia:** While cryoglobulinemia is a major cause of MPGN, it is frequently a *manifestation* of underlying Hepatitis C. In the context of NEET-PG, the viral trigger itself is considered the primary etiologic driver. * **C. Scleroderma:** This typically causes "Scleroderma Renal Crisis," characterized by malignant hypertension and "onion-skin" hypertrophy of arterioles, not an MPGN pattern. * **D. Lymphoma:** Chronic Lymphocytic Leukemia (CLL) and lymphomas can cause MPGN via monoclonal immunoglobulin deposition, but they are statistically less common than viral infections in the general adult population [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** Look for "Tram-track" appearance due to mesangial cell interposition [1]. * **Silver Stain:** Best stain to visualize the splitting of the basement membrane. * **Immunofluorescence:** MPGN Type I shows granular IgG and C3; Complement-mediated MPGN shows C3 only [1]. * **Association:** Always screen a patient with MPGN for Hepatitis C and Cryoglobulins [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 925-927. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 534-535.
Explanation: ### Explanation **Cholemic Nephrosis** (also known as Bile Acid Nephropathy) refers to the spectrum of renal morphological changes and dysfunction occurring in patients with severe jaundice. **1. Why Obstructive Jaundice is Correct:** In obstructive jaundice, there is a significant accumulation of **conjugated bilirubin** and **bile acids** in the systemic circulation [2, 5]. These substances are filtered by the glomerulus and reabsorbed by the proximal convoluted tubules. * **Pathogenesis:** High levels of bile salts and pigments are directly toxic to the renal tubular epithelial cells. * **Morphology:** Macroscopically, the kidneys appear enlarged and stained **greenish-yellow**. Microscopically, bile pigments are seen as greenish-brown casts or granules within the tubular lumina and cytoplasm, leading to tubular necrosis and potential acute kidney injury (AKI) [2]. **2. Why the Other Options are Incorrect:** * **A. Malaria:** Typically associated with "Blackwater Fever" (massive intravascular hemolysis), leading to **Hemoglobinuric Nephrosis**, not cholemic nephrosis. * **B. Addison’s Disease:** This is primary adrenocortical insufficiency. While it causes electrolyte imbalances (hyponatremia, hyperkalemia) and hypotension, it does not involve bile pigment deposition in the kidneys. * **C. Hemochromatosis:** Characterized by iron overload. While it affects the liver and pancreas (Bronze Diabetes), renal involvement involves **hemosiderin** deposition, not bile pigments. **3. High-Yield Clinical Pearls for NEET-PG:** * **Hepatorenal Syndrome (HRS):** Distinguish Cholemic Nephrosis (structural damage due to bile) from HRS (functional renal failure due to splanchnic vasodilation in cirrhosis). * **Bile Casts:** The presence of bile casts in urine sediment is a hallmark of Cholemic Nephrosis. * **Key Association:** It is most commonly seen in conditions with serum bilirubin levels exceeding **15–20 mg/dL**. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 384-385. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 866-868. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 380-381.
Explanation: **Explanation:** Renal involvement in leprosy is a significant cause of morbidity. The most common renal manifestation associated with leprosy, particularly the lepromatous pole, is **Secondary (AA) Amyloidosis**. This chronic inflammatory state leads to the deposition of amyloid fibrils in the glomeruli [4], which characteristically presents histologically as **Focal Segmental Glomerulosclerosis (FSGS)** or minimal change-like patterns before progressing to global sclerosis [1]. **Analysis of Options:** * **Focal Glomerulosclerosis (Correct):** In patients with leprosy, chronic immune stimulation and amyloid deposition frequently result in focal and segmental lesions [2]. Studies have shown that FSGS is a documented histological finding in renal biopsies of leprosy patients presenting with nephrotic syndrome [3]. * **Rapidly Progressive Glomerulonephritis (RPGN):** This is characterized by "crescents" and a rapid decline in renal function. While leprosy can cause various glomerulonephritides due to immune complex deposition (especially during Type 2 Lepra reactions), RPGN is not a standard or classic association. * **Membranoproliferative Glomerulonephritis (MPGN):** Though immune-complex mediated GN can occur in leprosy, MPGN is more classically associated with Hepatitis C or systemic lupus erythematosus rather than leprosy [2]. * **Acute Glomerulonephritis (AGN):** Typically follows streptococcal infections (PSGN). While acute nephritic presentations can occur during Erythema Nodosum Leprosum (ENL), it is less characteristic than the sclerotic changes associated with chronic disease. **High-Yield Pearls for NEET-PG:** * **Most common renal lesion in Leprosy:** Secondary (AA) Amyloidosis. * **Most common Glomerulonephritis in Leprosy:** Diffuse Proliferative Glomerulonephritis (DPGN) or Membranous Nephropathy (secondary to immune complexes during reactions). * **Type 2 Lepra Reaction (ENL):** Often triggers acute renal episodes due to the deposition of circulating immune complexes (Type III Hypersensitivity). * **Clinical Presentation:** Patients often present with asymptomatic proteinuria or full-blown Nephrotic Syndrome [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 923-924. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 919-921. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 530-531. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 533-534.
Explanation: **Explanation:** **KIM-1 (Kidney Injury Molecule-1)** is a type I transmembrane glycoprotein that is not expressed in healthy renal tissue but is **markedly upregulated** in the proximal tubule epithelial cells following ischemic or nephrotoxic insults [1]. 1. **Why Acute Kidney Injury (AKI) is correct:** KIM-1 is considered a "real-time" biomarker for AKI. Following an injury, the ectodomain of KIM-1 is shed into the urine, making it a highly specific and sensitive urinary biomarker. Unlike Serum Creatinine, which is a functional marker that rises late, KIM-1 is a **structural damage marker** that can detect tubular injury much earlier. [1] 2. **Why other options are incorrect:** * **Chronic Kidney Disease (CKD):** While KIM-1 may be elevated in chronic states due to ongoing tubular stress, it is primarily validated and clinically utilized as a diagnostic tool for *acute* tubular necrosis and early AKI. * **Renal Cell Carcinoma (RCC) & Metastasis:** Though KIM-1 is overexpressed in some clear cell RCCs, it is not the primary clinical application for this biomarker. Standard markers for RCC include genetic studies (VHL gene) or imaging; KIM-1 is specifically tested in the context of acute tubular damage. **High-Yield Pearls for NEET-PG:** * **Other Novel AKI Biomarkers:** NGAL (Neutrophil Gelatinase-Associated Lipocalin), IL-18, and L-FABP. * **Location:** KIM-1 is specifically expressed in the **proximal convoluted tubule** [1]. * **Function:** It plays a role in phagocytosis, helping the tubules clear apoptotic and necrotic debris after an injury. * **Clinical Utility:** It predicts the need for dialysis and mortality in patients with AKI [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 931-934. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 520-521.
Explanation: ### Explanation **Pauci-immune Crescentic Glomerulonephritis (CrGN)** is characterized by rapid decline in renal function, the presence of crescents in >50% of glomeruli, and—crucially—the **absence or scarcity of immunoglobulin/complement deposits** on immunofluorescence (IF) [1]. #### Why Microscopic Polyangiitis (MPA) is Correct: MPA is a small-vessel vasculitis strongly associated with **ANCA (Antineutrophil Cytoplasmic Antibodies)**, specifically p-ANCA (anti-MPO). In the kidneys, it manifests as a necrotizing, crescentic GN [2]. Because the damage is mediated by activated neutrophils rather than immune-complex deposition, the IF remains "pauci-immune" (negative) [1]. Other members of this group include Granulomatosis with Polyangiitis (GPA) and Eosinophilic Granulomatosis with Polyangiitis (EGPA). #### Why the Other Options are Incorrect: * **Henoch-Schönlein Nephritis (IgA Vasculitis):** This is an **immune-complex mediated** disease. IF shows characteristic granular **IgA deposits** in the mesangium. * **Lupus Nephritis (SLE):** This is the classic "full-house" immune-complex disease. IF shows granular deposits of **IgG, IgA, IgM, C3, and C4**. * **Alport Syndrome:** This is a **genetic disorder** caused by mutations in Type IV collagen. It does not typically present with crescents or immune deposits; instead, it shows thinning/splitting of the Glomerular Basement Membrane (GBM) on electron microscopy ("basket-weave" appearance). #### High-Yield Clinical Pearls for NEET-PG: 1. **Classification of CrGN:** * **Type I:** Anti-GBM disease (Linear IgG deposits; e.g., Goodpasture Syndrome). * **Type II:** Immune-complex mediated (Granular deposits; e.g., PSGN, SLE, IgA Nephropathy). * **Type III:** Pauci-immune (ANCA-associated; e.g., MPA, GPA) [1]. 2. **Crescent Composition:** Formed by the proliferation of **parietal epithelial cells** and the migration of **monocytes/macrophages** into Bowman’s space. 3. **Serology:** MPA is typically **p-ANCA** positive, while GPA is typically **c-ANCA** (anti-PR3) positive [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 917-918. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 536-537.
Explanation: **Explanation:** The clinical presentation of hematuria and acute renal failure associated with **crescentic glomerulonephritis** (Rapidly Progressive Glomerulonephritis - RPGN) indicates severe glomerular injury. In **Acute Post-Infectious Glomerulonephritis (PSGN)**, while most cases present as a typical nephritic syndrome, approximately 3% can progress to a "Crescentic" (Type IV) pattern [1, 3]. Immunofluorescence (IF) in PSGN characteristically shows a **"starry sky" or granular pattern** of **IgG and C3** deposition along the basement membrane and mesangium [1, 2]. **Why other options are incorrect:** * **Membranous Glomerulonephritis:** Typically presents with nephrotic syndrome, not acute renal failure or crescents [1]. IF shows granular IgG and C3, but the pathology shows diffuse capillary wall thickening, not crescents. * **Minimal Change Disease:** The most common cause of nephrotic syndrome in children. It shows normal glomeruli on light microscopy and **negative** immunofluorescence. * **Monoclonal Deposition Disease:** Associated with plasma cell dyscrasias. IF would show light chain restriction (either Kappa or Lambda), not a combined IgG and C3 pattern typical of post-infectious processes. **NEET-PG High-Yield Pearls:** * **Crescents** are formed by the proliferation of parietal epithelial cells and the migration of monocytes/macrophages into Bowman’s space [4]. * **PSGN Electron Microscopy:** Characterized by subepithelial **"humps."** [1, 2] * **RPGN Classification:** * Type I: Anti-GBM (Linear IF) [1] * Type II: Immune Complex (Granular IF) - *Includes PSGN, SLE, HSP.* * Type III: Pauci-immune (ANCA associated). * Low serum **C3 levels** are a hallmark of the acute phase of PSGN. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, p. 915. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 536-537. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 915-916. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 528-529.
Explanation: ### Explanation **Correct Answer: C. Squamous cell carcinoma of the bladder** **Mechanism and Pathophysiology:** *Schistosoma haematobium* is a trematode (blood fluke) that deposits its eggs in the venous plexus of the urinary bladder [1]. The presence of these eggs triggers a chronic inflammatory response and granuloma formation [1]. Over time, the chronic irritation leads to **Squamous Metaplasia** of the normal urothelium (transitional epithelium). If the irritation persists, this metaplastic tissue undergoes malignant transformation into **Squamous Cell Carcinoma (SCC)**. While SCC accounts for only ~5% of bladder cancers in the West, it is the most common type in endemic areas (e.g., Egypt/Nile Valley) due to Schistosomiasis. **Analysis of Incorrect Options:** * **A & B (Adenocarcinoma):** Adenocarcinoma of the bladder is rare and typically associated with **urachal remnants** (at the dome of the bladder) or **cystitis glandularis**. It is not the primary malignancy associated with Schistosomiasis. * **D (Transitional Cell Carcinoma/Urothelial Carcinoma):** This is the most common type of bladder cancer worldwide (>90%) [2]. Its primary risk factors include **smoking**, exposure to **aniline dyes** (naphthylamine), and cyclophosphamide. While it can occur in patients with Schistosomiasis, SCC is the specific and characteristic association tested in exams. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site for Schistosoma eggs:** The posterior wall of the bladder near the ureteric orifices. * **Characteristic finding:** "Sandy patches" on cystoscopy (calcified eggs in the mucosa). * **Calcification:** Look for "curvilinear" or "eggshell" calcification of the bladder wall on X-ray. * **Other Schistosoma species:** *S. mansoni* and *S. japonicum* are primarily associated with portal hypertension and liver fibrosis, not bladder cancer [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 405-406. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 972-973.
Explanation: **Explanation:** **Nodular Glomerulosclerosis**, also known as **Kimmelstiel-Wilson (KW) lesions**, is a pathognomonic histological finding of **Diabetic Nephropathy** [1]. These are ovoid, laminated, hyaline eosinophilic nodules located in the periphery of the glomerulus, resulting from an increase in mesangial matrix and basement membrane thickening due to non-enzymatic glycosylation of proteins [2]. **Analysis of Options:** * **Diabetes Mellitus (Correct):** It presents with two types of glomerulosclerosis: Diffuse (most common) and Nodular (most specific) [1]. The nodules are PAS-positive and represent advanced glomerular damage [1]. * **Malignant Hypertension:** Characterized by **Fibrinoid necrosis** of arterioles and **"Onion-skin" thickening** of the vessel walls (hyperplastic arteriolosclerosis), not nodular mesangial expansion [3]. * **Amyloidosis:** While it can show nodular deposits, these are composed of Congo Red-positive fibrils with apple-green birefringence under polarized light [4]. Unlike KW nodules, amyloid deposits are typically PAS-negative or weakly positive. * **Multiple Myeloma:** Primarily affects the tubules (**Myeloma Kidney** or Cast Nephropathy) due to Bence-Jones proteins [4]. While it can cause AL-Amyloidosis or Light Chain Deposition Disease (which can mimic nodules), it is not the classic association for "Nodular Glomerulosclerosis." **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Clinical Sign:** Microalbuminuria (30–300 mg/day). * **Earliest Morphological Change:** Thickening of the Glomerular Basement Membrane (GBM) [1]. * **Pathognomonic Feature:** Kimmelstiel-Wilson nodules. * **Associated Finding:** Armanni-Ebstein lesions (glycogen deposits in renal tubular epithelial cells). * **Stain:** PAS (Periodic Acid-Schiff) stain strongly highlights the nodules [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1121-1122. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 907-908. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 498-499. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 533-534.
Explanation: **Explanation:** Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a systemic hereditary disorder characterized by the progressive formation of fluid-filled cysts in the renal parenchyma. 1. **Bilateral Enlargement (Option A):** ADPKD is always a bilateral process [1]. The kidneys can reach massive sizes, sometimes weighing up to 4 kg each, and are often palpable on physical examination [2]. 2. **External Surface (Option B):** Macroscopically, the kidneys are replaced by a mass of cysts. These cysts vary in size (up to 3-4 cm) and contain clear, turbid, or hemorrhagic fluid [2]. The external surface appears bosselated or "bumpy" due to these protruding cysts. 3. **Histology (Option C):** Unlike multicystic dysplastic kidney (where no normal tissue exists), ADPKD histology reveals islands of **functioning nephrons** and normal parenchyma interspersed between the cysts. This explains why renal function is often preserved until the fourth or fifth decade of life, despite the presence of numerous cysts [1]. Since all statements accurately describe the pathology of ADPKD, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Genetics:** Most commonly due to mutations in **PKD1** (Chromosome 16, encodes Polycystin-1) which is more severe, or **PKD2** (Chromosome 4, encodes Polycystin-2) [1]. * **Extra-renal Manifestations:** * **Liver:** Polycystic liver disease (most common extra-renal site). * **CNS:** Berry aneurysms in the Circle of Willis (can lead to Subarachnoid Hemorrhage). * **Heart:** Mitral Valve Prolapse (MVP). * **Other:** Diverticulosis of the colon and seminal vesicle cysts. * **Radiology:** Ultrasound is the initial screening modality of choice. **Key Concepts:** Dysfunction of the primary cilium is the underlying mechanism [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 950-951. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 544-545. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 954-955.
Explanation: ### Explanation In renal transplantation, the **vascular endothelium** is the primary target for the early immunological attack, particularly in **Hyperacute** and **Acute Antibody-Mediated Rejection (AMR)** [1], [2]. **Why Vascular Endothelium is the Correct Answer:** The endothelium of the graft's capillaries and arterioles is the first point of contact between the recipient's immune system (antibodies and T-cells) and the donor organ [2]. In hyperacute rejection, pre-formed antibodies bind to ABO or HLA antigens on the endothelial surface, triggering the complement cascade, leading to thrombosis and graft necrosis [3]. In acute rejection, both antibodies and T-lymphocytes target the peritubular capillaries and small vessels, a process known as **capillaritis** and **endothelialitis** [1], [4]. **Why Other Options are Incorrect:** * **Renal Papillae:** These are sites of damage in analgesic nephropathy or sickle cell trait (papillary necrosis), not the primary target of transplant rejection. * **Glomeruli:** While "Glomerulitis" can occur during rejection, it is usually secondary to the initial endothelial damage in the microvasculature [1]. * **Proximal Tubules:** Tubulitis (T-cell infiltration of tubules) is a hallmark of **Acute Cellular Rejection**, but the initial vascular recognition by the immune system typically precedes or occurs alongside this [4]. **High-Yield Clinical Pearls for NEET-PG:** * **Hyperacute Rejection:** Occurs within minutes/hours; Type II Hypersensitivity; characterized by widespread **thrombotic microangiopathy** [3]. * **Acute Cellular Rejection:** Characterized by **Tubulitis** and **Endothelialitis** (Type IV Hypersensitivity) [4]. * **C4d Staining:** A crucial diagnostic marker for **Antibody-Mediated Rejection**, as it represents a degradation product of the classical complement pathway deposited on the peritubular capillaries [1]. * **Chronic Rejection:** Characterized by **intimal thickening** (onion-skinning) and graft fibrosis [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 546-549. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 180-181. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 241-242. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 242.
Congenital Anomalies of the Kidney
Practice Questions
Glomerular Diseases
Practice Questions
Tubular and Interstitial Diseases
Practice Questions
Vascular Diseases of the Kidney
Practice Questions
Cystic Diseases of the Kidney
Practice Questions
Urinary Tract Obstruction and Stones
Practice Questions
Renal Tumors
Practice Questions
Kidney in Systemic Diseases
Practice Questions
Renal Transplantation Pathology
Practice Questions
Urinary Tract Infections
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free